organization · Reporting owner

Eclipse Fund III, L.P.

Disclosed activity across 2 companies

Tapewire entity: 124376
SEC CIK: 0001763853

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Lucira Health, Inc.LHDX · Entity 115613	10% owner	February 09, 2021	February 09, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Lucira Health, Inc.

Report date February 09, 2021 · Filed February 09, 2021

Jointly reported with Eclipse GP III, LLC, Eclipse Ventures Fund I, L.P., Eclipse Ventures GP I, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnote	2,039,809	Last balance in matching sequence After 2021-02-09 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 1 · 2021-02-09 · Conversion · Acquired 976,852 · Balance 976,852 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Row 2 · 2021-02-09 · Conversion · Acquired 877,445 · Balance 1,854,297 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Row 3 · 2021-02-09 · Conversion · Acquired 185,512 · Balance 2,039,809 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
Common StockSEC Table I · non-derivative	Direct	4,183,986	Last balance in matching sequence After 2021-02-09 transaction · row 5 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 4 · 2021-02-09 · Conversion · Acquired 3,710,257 · Balance 3,710,257 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F3: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any. Row 5 · 2021-02-09 · Conversion · Acquired 473,729 · Balance 4,183,986 F3: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any.
Series A Preferred StockSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2021-02-09 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-02-09 · Conversion · Disposed 976,852 · Balance 0 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
Series B Preferred StockSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2021-02-09 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-02-09 · Conversion · Disposed 877,445 · Balance 0 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2021-02-09 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2021-02-09 · Conversion · Disposed 185,512 · Balance 0 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
Series C Preferred StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-02-09 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2021-02-09 · Conversion · Disposed 3,710,257 · Balance 0 F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F3: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any.
Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $13.60 · Expires 2022-12-11	Direct	0	Reported balance After 2021-02-09 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-02-09 · Conversion · Disposed Not disclosed · Balance 0 F4: The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO. F3: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.

F2: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.

F3: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any.

F4: The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Enovix Corp

Report date August 18, 2022 · Filed August 19, 2022

Jointly reported with Eclipse GP III, LLC

Section 16 reporting ended · disclosed 2022-08-19. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnote	12,583,258	Reported balance After 2022-08-18 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2022-08-18 · Other · Disposed 5,000,000 · Balance 12,583,258 F1: Represents a pro rata in-kind distribution, and not a purchase or sale, without additional consideration by Eclipse Fund III, L.P. ("Eclipse III") to its general and limited partners. F2: The securities are held directly by Eclipse III. Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of his pecuniary interests therein, if any.
Common StockSEC Table I · non-derivative	Direct	0	Last balance in matching sequence After 2022-08-18 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 2 · 2022-08-18 · Other · Acquired 50,000 · Balance 50,000 F3: Represents a change in the form of ownership of Eclipse III GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Eclipse III. F4: The securities are held directly by Eclipse III GP. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III GP. Mr. Susan disclaims beneficial ownership of the shares held by Eclipse III GP except to the extent of his pecuniary interests therein, if any. Row 3 · 2022-08-18 · Other · Disposed 50,000 · Balance 0 F5: Represents a pro-rata in-kind distribution, and not a purchase or sale, without additional consideration by Eclipse III GP to its members. F4: The securities are held directly by Eclipse III GP. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III GP. Mr. Susan disclaims beneficial ownership of the shares held by Eclipse III GP except to the extent of his pecuniary interests therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a pro rata in-kind distribution, and not a purchase or sale, without additional consideration by Eclipse Fund III, L.P. ("Eclipse III") to its general and limited partners.

F2: The securities are held directly by Eclipse III. Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of his pecuniary interests therein, if any.

F3: Represents a change in the form of ownership of Eclipse III GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Eclipse III.

F4: The securities are held directly by Eclipse III GP. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III GP. Mr. Susan disclaims beneficial ownership of the shares held by Eclipse III GP except to the extent of his pecuniary interests therein, if any.

F5: Represents a pro-rata in-kind distribution, and not a purchase or sale, without additional consideration by Eclipse III GP to its members.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 18, 2022 Filed Aug 19, 2022 16:54 UTC	Enovix Corp ENVX · Entity 5188	OtherCommon Stock	50,000	$0.00	$0.00	Disclosure SEC source: 0000899243-22-029293 · doc4.xml · nonDerivative · entry 3 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · kind: Represents a pro-rata in-kind distribution, and not a purchase or sale, without additional consideration by Eclipse III GP to its members. F4 · ownership.direct: The securities are held directly by Eclipse III GP. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III GP. Mr. Susan disclaims beneficial ownership of the shares held by Eclipse III GP except to the extent of his pecuniary interests therein, if any. Read SEC document
August 18, 2022 Filed Aug 19, 2022 16:54 UTC	Enovix Corp ENVX · Entity 5188	OtherCommon Stock	50,000	$0.00	$0.00	Disclosure SEC source: 0000899243-22-029293 · doc4.xml · nonDerivative · entry 2 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F3 · kind: Represents a change in the form of ownership of Eclipse III GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Eclipse III. F4 · ownership.direct: The securities are held directly by Eclipse III GP. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III GP. Mr. Susan disclaims beneficial ownership of the shares held by Eclipse III GP except to the extent of his pecuniary interests therein, if any. Read SEC document
August 18, 2022 Filed Aug 19, 2022 16:54 UTC	Enovix Corp ENVX · Entity 5188	OtherCommon Stock	5,000,000	$0.00	$0.00	Disclosure SEC source: 0000899243-22-029293 · doc4.xml · nonDerivative · entry 1 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 12,583,258 F1 · kind: Represents a pro rata in-kind distribution, and not a purchase or sale, without additional consideration by Eclipse Fund III, L.P. ("Eclipse III") to its general and limited partners. F2 · ownership.nature: The securities are held directly by Eclipse III. Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Lior Susan is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of his pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionConvertible Promissory Note · Derivative	Not disclosed	$0.00 Strike: $13.60	$6,442,717.58	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · derivative · entry 10 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 473,729 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO. F3 · ownership.direct: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionSeries C Preferred Stock · Derivative	3,710,257	$0.00	$0.00	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · derivative · entry 9 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,710,257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F3 · ownership.direct: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionSeries C Preferred Stock · Derivative	185,512	$0.00	$0.00	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · derivative · entry 8 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 185,512 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionSeries B Preferred Stock · Derivative	877,445	$0.00	$0.00	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · derivative · entry 7 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 877,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionSeries A Preferred Stock · Derivative	976,852	$0.00	$0.00	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · derivative · entry 6 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 976,852 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionCommon Stock	473,729	$13.60	$6,442,714.40	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · nonDerivative · entry 5 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,183,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.direct: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionCommon Stock	3,710,257	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · nonDerivative · entry 4 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,710,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F3 · ownership.direct: The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionCommon Stock	185,512	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · nonDerivative · entry 3 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,039,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionCommon Stock	877,445	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · nonDerivative · entry 2 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,854,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document
February 09, 2021 Filed Feb 9, 2021 19:57 UTC	Lucira Health, Inc. LHDX · Entity 115613	ConversionCommon Stock	976,852	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-009051 · doc4.xml · nonDerivative · entry 1 Eclipse GP III, LLC · CIK 0001763854 · 10% owner Eclipse Fund III, L.P. · CIK 0001763853 · 10% owner Eclipse Ventures Fund I, L.P. · CIK 0001641394 · 10% owner Eclipse Ventures GP I, LLC · CIK 0001843678 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 976,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date. F2 · ownership.nature: The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.